|
End-of-day quote
Thailand S.E.
01/10/2026
|
5-day change | 1st Jan Change | ||
| 34.00 THB | +0.74% |
|
-1.45% | +1.49% |
Company Valuation: Mega Lifesciences
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 44,029 | 40,760 | 35,093 | 28,990 | 29,208 | 29,644 | - | - |
| Change | - | -7.43% | -13.9% | -17.39% | 0.75% | 1.49% | - | - |
| Enterprise Value (EV) 1 | 41,666 | 38,309 | 32,456 | 25,464 | 25,051 | 25,027 | 24,924 | 24,590 |
| Change | - | -8.06% | -15.28% | -21.54% | -1.62% | -0.1% | -0.41% | -1.34% |
| P/E | 22.6x | 18.2x | 17.6x | 14.4x | 15.3x | 12.5x | 11.9x | 11.2x |
| PBR | 5.5x | 4.64x | 3.77x | 2.94x | 2.86x | 2.78x | 2.67x | 2.57x |
| PEG | - | 1.2x | -1.6x | 16.49x | -2.95x | 0.5x | 2.28x | 1.69x |
| Capitalization / Revenue | 3.08x | 2.6x | 2.24x | 1.89x | 2.06x | 2.07x | 1.89x | 1.8x |
| EV / Revenue | 2.91x | 2.44x | 2.07x | 1.66x | 1.77x | 1.74x | 1.59x | 1.49x |
| EV / EBITDA | 17.2x | 13x | 10.2x | 6.78x | 8.73x | 7.94x | 7.06x | 6.55x |
| EV / EBIT | 18.1x | 14.3x | 11.2x | 7.56x | 9.69x | 9.11x | 7.84x | 7.27x |
| EV / FCF | 16.2x | 22.6x | 19.6x | 11.8x | 11.9x | 12.1x | 11.4x | 10.9x |
| FCF Yield | 6.18% | 4.42% | 5.09% | 8.46% | 8.41% | 8.24% | 8.76% | 9.17% |
| Dividend per Share 2 | 1.06 | 1.61 | 1.65 | 1.6 | 1.6 | 1.76 | 1.897 | 2.021 |
| Rate of return | 2.1% | 3.44% | 4.1% | 4.81% | 4.78% | 5.18% | 5.58% | 5.95% |
| EPS 2 | 2.23 | 2.57 | 2.29 | 2.31 | 2.19 | 2.71 | 2.851 | 3.04 |
| Distribution rate | 47.5% | 62.6% | 72.1% | 69.3% | 73.1% | 64.9% | 66.5% | 66.5% |
| Net sales 1 | 14,301 | 15,686 | 15,681 | 15,344 | 14,147 | 14,347 | 15,664 | 16,457 |
| EBITDA 1 | 2,426 | 2,953 | 3,190 | 3,756 | 2,868 | 3,150 | 3,529 | 3,756 |
| EBIT 1 | 2,305 | 2,681 | 2,904 | 3,370 | 2,585 | 2,748 | 3,180 | 3,383 |
| Net income 1 | 1,947 | 2,242 | 1,993 | 2,012 | 1,912 | 2,231 | 2,485 | 2,652 |
| Net Debt 1 | -2,363 | -2,451 | -2,636 | -3,525 | -4,156 | -4,617 | -4,720 | -5,053 |
| Reference price 2 | 50.50 | 46.75 | 40.25 | 33.25 | 33.50 | 34.00 | 34.00 | 34.00 |
| Nbr of stocks (in thousands) | 871,870 | 871,870 | 871,870 | 871,870 | 871,870 | 871,870 | - | - |
| Announcement Date | 2/23/22 A | 2/25/23 A | 2/22/24 A | 2/24/25 A | 2/24/26 A | - | - | - |
1THB in Million2THB
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 12.45x | 1.73x | 7.88x | 5.21% | 876M | ||
| 32.9x | 11.93x | 24.23x | 0.6% | 1,031B | ||
| 29.45x | 6.54x | 18.31x | 2.02% | 638B | ||
| 33.1x | 7.75x | 16.02x | 2.65% | 462B | ||
| 105.72x | 5.91x | 25.05x | 2.35% | 359B | ||
| 19x | 4.63x | 11.48x | 2.87% | 335B | ||
| 20.37x | 5.28x | 13.08x | 3.03% | 273B | ||
| 20.79x | 4.31x | 12.28x | 2.05% | 253B | ||
| 26.62x | 6.92x | 12.32x | 2.39% | 228B | ||
| -45.08x | 6.57x | 25.65x | 2.21% | 185B | ||
| Average | 25.53x | 6.16x | 16.63x | 2.54% | 376.47B | |
| Weighted average by Cap. | 32.10x | 7.72x | 18.90x | 1.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MEGA Stock
- Valuation Mega Lifesciences
Select your edition
All financial news and data tailored to specific country editions
















